Latest Insights
Subscribe for relevant insights delivered straight to your inbox

One Down, Three to Go
Updated strategist predictions for 2022 and a look at the relationship between first quarter and rest of year returns.

2022 – optimal conditions for a liquid alternative toolset?
How can a multi-strategy approach to using liquid alternatives help to improve diversification and complement traditional asset class allocations?

Keep calm and (commodity) carry on
Volatility and noise in financial markets increased markedly in the first quarter of 2022. Can investors find a useful signal in commodity markets that can shed some light in a somewhat uncertain world?

Beating the biotech blues
The biotech sector is experiencing its worst period of relative underperformance on record. But some of history’s biggest biotech pains have been followed by memorable gains.